Sclerotherapy for bleeding esophageal varices after randomized trials

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Endoscopic sclerotherapy remains an uncertain therapy for bleeding esophageal varices. Several recently reported randomized trials address the efficacy of immediate, long-term and prophylactic sclerotherapy. Analysis of these studies suggests that sclerotherapy may stop acute bleeding but has little impact on survival of an acute bleeding episode. Ongoing sclerosis reduces the incidence of rebleeding episodes and improves survival for those patients fortunate enough to survive the acute bleeding episode. Prophylactic therapy is an exciting concept limited by difficulty in identifying 'high-risk' patients and by the high rate of complications associated with sclerotherapy.

Original languageEnglish (US)
Pages (from-to)481-484
Number of pages4
JournalWestern Journal of Medicine
Volume145
Issue number4
StatePublished - 1986

Fingerprint

Sclerotherapy
Esophageal and Gastric Varices
Hemorrhage
Survival
Sclerosis
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sclerotherapy for bleeding esophageal varices after randomized trials. / Lieberman, David.

In: Western Journal of Medicine, Vol. 145, No. 4, 1986, p. 481-484.

Research output: Contribution to journalArticle

@article{aabde17fede24601816ecf13f3a4c11a,
title = "Sclerotherapy for bleeding esophageal varices after randomized trials",
abstract = "Endoscopic sclerotherapy remains an uncertain therapy for bleeding esophageal varices. Several recently reported randomized trials address the efficacy of immediate, long-term and prophylactic sclerotherapy. Analysis of these studies suggests that sclerotherapy may stop acute bleeding but has little impact on survival of an acute bleeding episode. Ongoing sclerosis reduces the incidence of rebleeding episodes and improves survival for those patients fortunate enough to survive the acute bleeding episode. Prophylactic therapy is an exciting concept limited by difficulty in identifying 'high-risk' patients and by the high rate of complications associated with sclerotherapy.",
author = "David Lieberman",
year = "1986",
language = "English (US)",
volume = "145",
pages = "481--484",
journal = "Western Journal of Medicine",
issn = "0093-0415",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Sclerotherapy for bleeding esophageal varices after randomized trials

AU - Lieberman, David

PY - 1986

Y1 - 1986

N2 - Endoscopic sclerotherapy remains an uncertain therapy for bleeding esophageal varices. Several recently reported randomized trials address the efficacy of immediate, long-term and prophylactic sclerotherapy. Analysis of these studies suggests that sclerotherapy may stop acute bleeding but has little impact on survival of an acute bleeding episode. Ongoing sclerosis reduces the incidence of rebleeding episodes and improves survival for those patients fortunate enough to survive the acute bleeding episode. Prophylactic therapy is an exciting concept limited by difficulty in identifying 'high-risk' patients and by the high rate of complications associated with sclerotherapy.

AB - Endoscopic sclerotherapy remains an uncertain therapy for bleeding esophageal varices. Several recently reported randomized trials address the efficacy of immediate, long-term and prophylactic sclerotherapy. Analysis of these studies suggests that sclerotherapy may stop acute bleeding but has little impact on survival of an acute bleeding episode. Ongoing sclerosis reduces the incidence of rebleeding episodes and improves survival for those patients fortunate enough to survive the acute bleeding episode. Prophylactic therapy is an exciting concept limited by difficulty in identifying 'high-risk' patients and by the high rate of complications associated with sclerotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0022976792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022976792&partnerID=8YFLogxK

M3 - Article

C2 - 3538660

AN - SCOPUS:0022976792

VL - 145

SP - 481

EP - 484

JO - Western Journal of Medicine

JF - Western Journal of Medicine

SN - 0093-0415

IS - 4

ER -